癌症：药物敏感性差异 - Suppr

Cancer: Discrepancies in drug sensitivity.

作者信息

Weinstein John N, Lorenzi Philip L

机构信息

Department of Bioinformatics and Computational Biology and the Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

出版信息

Nature. 2013 Dec 19;504(7480):381-3. doi: 10.1038/nature12839. Epub 2013 Nov 27.

DOI:10.1038/nature12839

PMID:24284624

Abstract

摘要

相似文献

Cancer: Discrepancies in drug sensitivity.

Nature. 2013 Dec 19;504(7480):381-3. doi: 10.1038/nature12839. Epub 2013 Nov 27.

Pharmacogenetics and pharmacogenomics as new tools to optimise cancer chemotherapy.

J Chemother. 2004 Nov;16 Suppl 4:22-4. doi: 10.1179/joc.2004.16.Supplement-1.22.

[Pharmacogenetics and tumor sensitivity of antineoplastic agents. Application to colorectal cancer].

Rev Prat. 2008 May 31;58(10):1056-9.

[Pharmacogenetics of antineoplastic agents designed for malignant cancers].

Nihon Naika Gakkai Zasshi. 2009 Aug 10;98(8):1846-53. doi: 10.2169/naika.98.1846.

Advances and challenges in fluoropyrimidine pharmacogenomics and pharmacogenetics.

Pharmacogenomics. 2005 Dec;6(8):835-47. doi: 10.2217/14622416.6.8.835.

Multidrug resistance-associated protein 4 in pharmacology: Overview of its contribution to pharmacokinetics, pharmacodynamics and pharmacogenetics.

Life Sci. 2019 Aug 15;231:116540. doi: 10.1016/j.lfs.2019.06.015. Epub 2019 Jun 7.

Host pharmacogenetics in the treatment of HIV and cancer.

Curr Drug Saf. 2006 Jan;1(1):107-16. doi: 10.2174/157488606775252683.

[Value and applications of pharmacogenetics in oncology and hematology].

Bull Cancer. 1997 Jun;84(6):643-51.

Pharmacogenetics and pediatric cancer.

Cancer J. 2005 Jul-Aug;11(4):314-23. doi: 10.1097/00130404-200507000-00007.

Pharmacogenetics and pharmacogenomics as tools in cancer therapy.

Drug Metab Pers Ther. 2016 Mar;31(1):25-34. doi: 10.1515/dmpt-2015-0042.

引用本文的文献

Ion suppression correction and normalization for non-targeted metabolomics.

Nat Commun. 2025 Feb 4;16(1):1347. doi: 10.1038/s41467-025-56646-8.

Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based Resource.

Mol Cancer Ther. 2023 Nov 1;22(11):1270-1279. doi: 10.1158/1535-7163.MCT-23-0267.

To share is to be a scientist.

Nat Methods. 2023 Jul;20(7):984-989. doi: 10.1038/s41592-023-01927-7.

An EGFR signature predicts cell line and patient sensitivity to multiple tyrosine kinase inhibitors.

Int J Cancer. 2020 Nov 1;147(9):2621-2633. doi: 10.1002/ijc.33053. Epub 2020 Jun 4.

Computational Methods for the Integrative Analysis of Genomics and Pharmacological Data.

Front Oncol. 2020 Feb 27;10:185. doi: 10.3389/fonc.2020.00185. eCollection 2020.

Evaluating the consistency of large-scale pharmacogenomic studies.

Brief Bioinform. 2019 Sep 27;20(5):1734-1753. doi: 10.1093/bib/bby046.

Nonlinear mixed-effects models for modeling in vitro drug response data to determine problematic cancer cell lines.

Sci Rep. 2019 Oct 8;9(1):14421. doi: 10.1038/s41598-019-50936-0.

Quality Control of Quantitative High Throughput Screening Data.

Front Genet. 2019 May 9;10:387. doi: 10.3389/fgene.2019.00387. eCollection 2019.

State-of-the-art strategies for targeting the DNA damage response in cancer.

Nat Rev Clin Oncol. 2019 Feb;16(2):81-104. doi: 10.1038/s41571-018-0114-z.

Systematic identification of non-coding pharmacogenomic landscape in cancer.

Nat Commun. 2018 Aug 9;9(1):3192. doi: 10.1038/s41467-018-05495-9.

本文引用的文献

Inconsistency in large pharmacogenomic studies.

Nature. 2013 Dec 19;504(7480):389-93. doi: 10.1038/nature12831. Epub 2013 Nov 27.

The Cancer Genome Atlas Pan-Cancer analysis project.

Nat Genet. 2013 Oct;45(10):1113-20. doi: 10.1038/ng.2764.

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Nature. 2012 Mar 28;483(7391):603-7. doi: 10.1038/nature11003.

Systematic identification of genomic markers of drug sensitivity in cancer cells.

Nature. 2012 Mar 28;483(7391):570-5. doi: 10.1038/nature11005.

An information-intensive approach to the molecular pharmacology of cancer.

Science. 1997 Jan 17;275(5298):343-9. doi: 10.1126/science.275.5298.343.

Development of human tumor cell line panels for use in disease-oriented drug screening.

Prog Clin Biol Res. 1988;276:265-86.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Cancer: Discrepancies in drug sensitivity.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献